Table of Content

1 Leukocyte Surface Antigen CD47 Market Overview
1.1 Leukocyte Surface Antigen CD47 Product Scope
1.2 Leukocyte Surface Antigen CD47 Segment by Type
1.2.1 Global Leukocyte Surface Antigen CD47 Sales by Type (2016 & 2021 & 2027)
1.2.2 B-6H12
1.2.3 ALX-148
1.2.4 CC-90002
1.2.5 PSTx-23
1.2.6 Others
1.3 Leukocyte Surface Antigen CD47 Segment by Application
1.3.1 Global Leukocyte Surface Antigen CD47 Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Lymphoma
1.3.3 Ovarian Cancer
1.3.4 Ischemia Reperfusion Injury
1.3.5 Kindney Transplant Rejection
1.3.6 Others
1.4 Leukocyte Surface Antigen CD47 Market Estimates and Forecasts (2016-2027)
1.4.1 Global Leukocyte Surface Antigen CD47 Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Leukocyte Surface Antigen CD47 Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Leukocyte Surface Antigen CD47 Price Trends (2016-2027)

2 Leukocyte Surface Antigen CD47 Estimates and Forecasts by Region
2.1 Global Leukocyte Surface Antigen CD47 Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Leukocyte Surface Antigen CD47 Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Leukocyte Surface Antigen CD47 Sales Market Share by Region (2016-2021)
2.2.2 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2016-2021)
2.3 Global Leukocyte Surface Antigen CD47 Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Leukocyte Surface Antigen CD47 Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Leukocyte Surface Antigen CD47 Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Leukocyte Surface Antigen CD47 Estimates and Projections (2016-2027)
2.4.2 Europe Leukocyte Surface Antigen CD47 Estimates and Projections (2016-2027)
2.4.3 China Leukocyte Surface Antigen CD47 Estimates and Projections (2016-2027)
2.4.4 Japan Leukocyte Surface Antigen CD47 Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Leukocyte Surface Antigen CD47 Estimates and Projections (2016-2027)
2.4.6 India Leukocyte Surface Antigen CD47 Estimates and Projections (2016-2027)

3 Global Leukocyte Surface Antigen CD47 Competition Landscape by Players
3.1 Global Top Leukocyte Surface Antigen CD47 Players by Sales (2016-2021)
3.2 Global Top Leukocyte Surface Antigen CD47 Players by Revenue (2016-2021)
3.3 Global Leukocyte Surface Antigen CD47 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Leukocyte Surface Antigen CD47 as of 2020)
3.4 Global Leukocyte Surface Antigen CD47 Average Price by Company (2016-2021)
3.5 Manufacturers Leukocyte Surface Antigen CD47 Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Leukocyte Surface Antigen CD47 Market Size by Type
4.1 Global Leukocyte Surface Antigen CD47 Historic Market Review by Type (2016-2021)
4.1.1 Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2016-2021)
4.1.2 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2016-2021)
4.1.3 Global Leukocyte Surface Antigen CD47 Price by Type (2016-2021)
4.2 Global Leukocyte Surface Antigen CD47 Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Leukocyte Surface Antigen CD47 Sales Forecast by Type (2022-2027)
4.2.2 Global Leukocyte Surface Antigen CD47 Revenue Forecast by Type (2022-2027)
4.2.3 Global Leukocyte Surface Antigen CD47 Price Forecast by Type (2022-2027)

5 Global Leukocyte Surface Antigen CD47 Market Size by Application
5.1 Global Leukocyte Surface Antigen CD47 Historic Market Review by Application (2016-2021)
5.1.1 Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2016-2021)
5.1.2 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2016-2021)
5.1.3 Global Leukocyte Surface Antigen CD47 Price by Application (2016-2021)
5.2 Global Leukocyte Surface Antigen CD47 Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Leukocyte Surface Antigen CD47 Sales Forecast by Application (2022-2027)
5.2.2 Global Leukocyte Surface Antigen CD47 Revenue Forecast by Application (2022-2027)
5.2.3 Global Leukocyte Surface Antigen CD47 Price Forecast by Application (2022-2027)

6 North America Leukocyte Surface Antigen CD47 Market Facts & Figures
6.1 North America Leukocyte Surface Antigen CD47 Sales by Company
6.1.1 North America Leukocyte Surface Antigen CD47 Sales by Company (2016-2021)
6.1.2 North America Leukocyte Surface Antigen CD47 Revenue by Company (2016-2021)
6.2 North America Leukocyte Surface Antigen CD47 Sales Breakdown by Type
6.2.1 North America Leukocyte Surface Antigen CD47 Sales Breakdown by Type (2016-2021)
6.2.2 North America Leukocyte Surface Antigen CD47 Sales Breakdown by Type (2022-2027)
6.3 North America Leukocyte Surface Antigen CD47 Sales Breakdown by Application
6.3.1 North America Leukocyte Surface Antigen CD47 Sales Breakdown by Application (2016-2021)
6.3.2 North America Leukocyte Surface Antigen CD47 Sales Breakdown by Application (2022-2027)

7 Europe Leukocyte Surface Antigen CD47 Market Facts & Figures
7.1 Europe Leukocyte Surface Antigen CD47 Sales by Company
7.1.1 Europe Leukocyte Surface Antigen CD47 Sales by Company (2016-2021)
7.1.2 Europe Leukocyte Surface Antigen CD47 Revenue by Company (2016-2021)
7.2 Europe Leukocyte Surface Antigen CD47 Sales Breakdown by Type
7.2.1 Europe Leukocyte Surface Antigen CD47 Sales Breakdown by Type (2016-2021)
7.2.2 Europe Leukocyte Surface Antigen CD47 Sales Breakdown by Type (2022-2027)
7.3 Europe Leukocyte Surface Antigen CD47 Sales Breakdown by Application
7.3.1 Europe 119 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 119 Sales Breakdown by Application (2022-2027)

8 China Leukocyte Surface Antigen CD47 Market Facts & Figures
8.1 China Leukocyte Surface Antigen CD47 Sales by Company
8.1.1 China Leukocyte Surface Antigen CD47 Sales by Company (2016-2021)
8.1.2 China Leukocyte Surface Antigen CD47 Revenue by Company (2016-2021)
8.2 China Leukocyte Surface Antigen CD47 Sales Breakdown by Type
8.2.1 China Leukocyte Surface Antigen CD47 Sales Breakdown by Type (2016-2021)
8.2.2 China Leukocyte Surface Antigen CD47 Sales Breakdown by Type (2022-2027)
8.3 China Leukocyte Surface Antigen CD47 Sales Breakdown by Application
8.3.1 China 142 Sales Breakdown by Application (2016-2021)
8.3.2 China 142 Sales Breakdown by Application (2022-2027)

9 Japan Leukocyte Surface Antigen CD47 Market Facts & Figures
9.1 Japan Leukocyte Surface Antigen CD47 Sales by Company
9.1.1 Japan Leukocyte Surface Antigen CD47 Sales by Company (2016-2021)
9.1.2 Japan Leukocyte Surface Antigen CD47 Revenue by Company (2016-2021)
9.2 Japan Leukocyte Surface Antigen CD47 Sales Breakdown by Type
9.2.1 Japan Leukocyte Surface Antigen CD47 Sales Breakdown by Type (2016-2021)
9.2.2 Japan Leukocyte Surface Antigen CD47 Sales Breakdown by Type (2022-2027)
9.3 Japan Leukocyte Surface Antigen CD47 Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Leukocyte Surface Antigen CD47 Market Facts & Figures
10.1 Southeast Asia Leukocyte Surface Antigen CD47 Sales by Company
10.1.1 Southeast Asia Leukocyte Surface Antigen CD47 Sales by Company (2016-2021)
10.1.2 Southeast Asia Leukocyte Surface Antigen CD47 Revenue by Company (2016-2021)
10.2 Southeast Asia Leukocyte Surface Antigen CD47 Sales Breakdown by Type
10.2.1 Southeast Asia Leukocyte Surface Antigen CD47 Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Leukocyte Surface Antigen CD47 Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Leukocyte Surface Antigen CD47 Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Leukocyte Surface Antigen CD47 Market Facts & Figures
11.1 India Leukocyte Surface Antigen CD47 Sales by Company
11.1.1 India Leukocyte Surface Antigen CD47 Sales by Company (2016-2021)
11.1.2 India Leukocyte Surface Antigen CD47 Revenue by Company (2016-2021)
11.2 India Leukocyte Surface Antigen CD47 Sales Breakdown by Type
11.2.1 India Leukocyte Surface Antigen CD47 Sales Breakdown by Type (2016-2021)
11.2.2 India Leukocyte Surface Antigen CD47 Sales Breakdown by Type (2022-2027)
11.3 India Leukocyte Surface Antigen CD47 Sales Breakdown by Application
11.3.1 India Leukocyte Surface Antigen CD47 Sales Breakdown by Application (2016-2021)
11.3.2 India Leukocyte Surface Antigen CD47 Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Leukocyte Surface Antigen CD47 Business
12.1 Aurigene Discovery Technologies Ltd
12.1.1 Aurigene Discovery Technologies Ltd Corporation Information
12.1.2 Aurigene Discovery Technologies Ltd Business Overview
12.1.3 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Products Offered
12.1.5 Aurigene Discovery Technologies Ltd Recent Development
12.2 Celgene Corp
12.2.1 Celgene Corp Corporation Information
12.2.2 Celgene Corp Business Overview
12.2.3 Celgene Corp Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Celgene Corp Leukocyte Surface Antigen CD47 Products Offered
12.2.5 Celgene Corp Recent Development
12.3 Forty Seven Inc
12.3.1 Forty Seven Inc Corporation Information
12.3.2 Forty Seven Inc Business Overview
12.3.3 Forty Seven Inc Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Forty Seven Inc Leukocyte Surface Antigen CD47 Products Offered
12.3.5 Forty Seven Inc Recent Development
12.4 Surface Oncology Inc
12.4.1 Surface Oncology Inc Corporation Information
12.4.2 Surface Oncology Inc Business Overview
12.4.3 Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Surface Oncology Inc Leukocyte Surface Antigen CD47 Products Offered
12.4.5 Surface Oncology Inc Recent Development
12.5 Trillium Therapeutics Inc
12.5.1 Trillium Therapeutics Inc Corporation Information
12.5.2 Trillium Therapeutics Inc Business Overview
12.5.3 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Products Offered
12.5.5 Trillium Therapeutics Inc Recent Development
...

13 Leukocyte Surface Antigen CD47 Manufacturing Cost Analysis
13.1 Leukocyte Surface Antigen CD47 Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Leukocyte Surface Antigen CD47
13.4 Leukocyte Surface Antigen CD47 Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Leukocyte Surface Antigen CD47 Distributors List
14.3 Leukocyte Surface Antigen CD47 Customers

15 Market Dynamics
15.1 Leukocyte Surface Antigen CD47 Market Trends
15.2 Leukocyte Surface Antigen CD47 Drivers
15.3 Leukocyte Surface Antigen CD47 Market Challenges
15.4 Leukocyte Surface Antigen CD47 Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Leukocyte Surface Antigen CD47 Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Leukocyte Surface Antigen CD47 Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Leukocyte Surface Antigen CD47 Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Leukocyte Surface Antigen CD47 Sales (K Pcs) by Region (2016-2021)
Table 5. Global Leukocyte Surface Antigen CD47 Sales Market Share by Region (2016-2021)
Table 6. Global Leukocyte Surface Antigen CD47 Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Leukocyte Surface Antigen CD47 Revenue Share by Region (2016-2021)
Table 8. Global Leukocyte Surface Antigen CD47 Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Leukocyte Surface Antigen CD47 Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Leukocyte Surface Antigen CD47 Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Leukocyte Surface Antigen CD47 Revenue Share Forecast by Region (2022-2027)
Table 12. Global Leukocyte Surface Antigen CD47 Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Leukocyte Surface Antigen CD47 Sales Share by Company (2016-2021)
Table 14. Global Leukocyte Surface Antigen CD47 Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Leukocyte Surface Antigen CD47 Revenue Share by Company (2016-2021)
Table 16. Global Leukocyte Surface Antigen CD47 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leukocyte Surface Antigen CD47 as of 2020)
Table 17. Global Leukocyte Surface Antigen CD47 Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Leukocyte Surface Antigen CD47 Manufacturing Sites and Area Served
Table 19. Manufacturers Leukocyte Surface Antigen CD47 Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Leukocyte Surface Antigen CD47 Sales (K Pcs) by Type (2016-2021)
Table 22. Global Leukocyte Surface Antigen CD47 Sales Share by Type (2016-2021)
Table 23. Global Leukocyte Surface Antigen CD47 Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Leukocyte Surface Antigen CD47 Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Leukocyte Surface Antigen CD47 Sales Share by Type (2022-2027)
Table 26. Global Leukocyte Surface Antigen CD47 Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Leukocyte Surface Antigen CD47 Revenue Share by Type (2022-2027)
Table 28. Global Leukocyte Surface Antigen CD47 Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Leukocyte Surface Antigen CD47 Sales (K Pcs) by Application (2016-2021)
Table 30. Global Leukocyte Surface Antigen CD47 Sales Share by Application (2016-2021)
Table 31. Global Leukocyte Surface Antigen CD47 Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Leukocyte Surface Antigen CD47 Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Leukocyte Surface Antigen CD47 Sales (K Pcs) by Application (2022-2027)
Table 34. Global Leukocyte Surface Antigen CD47 Sales Share by Application (2022-2027)
Table 35. Global Leukocyte Surface Antigen CD47 Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Leukocyte Surface Antigen CD47 Revenue Share by Application (2022-2027)
Table 37. Global Leukocyte Surface Antigen CD47 Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Leukocyte Surface Antigen CD47 Sales (K Pcs) by Company (2016-2021)
Table 39. North America Leukocyte Surface Antigen CD47 Sales Market Share by Company (2016-2021)
Table 40. North America Leukocyte Surface Antigen CD47 Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Leukocyte Surface Antigen CD47 Revenue Market Share by Company (2016-2021)
Table 42. North America Leukocyte Surface Antigen CD47 Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Leukocyte Surface Antigen CD47 Sales Market Share by Type (2016-2021)
Table 44. North America Leukocyte Surface Antigen CD47 Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Leukocyte Surface Antigen CD47 Sales Market Share by Type (2022-2027)
Table 46. North America Leukocyte Surface Antigen CD47 Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Leukocyte Surface Antigen CD47 Sales Market Share by Application (2016-2021)
Table 48. North America Leukocyte Surface Antigen CD47 Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Leukocyte Surface Antigen CD47 Sales Market Share by Application (2022-2027)
Table 50. Europe Leukocyte Surface Antigen CD47 Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Company (2016-2021)
Table 52. Europe Leukocyte Surface Antigen CD47 Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Leukocyte Surface Antigen CD47 Revenue Market Share by Company (2016-2021)
Table 54. Europe Leukocyte Surface Antigen CD47 Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Type (2016-2021)
Table 56. Europe Leukocyte Surface Antigen CD47 Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Type (2022-2027)
Table 58. Europe Leukocyte Surface Antigen CD47 Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Application (2016-2021)
Table 60. Europe Leukocyte Surface Antigen CD47 Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Application (2022-2027)
Table 62. China Leukocyte Surface Antigen CD47 Sales (K Pcs) by Company (2016-2021)
Table 63. China Leukocyte Surface Antigen CD47 Sales Market Share by Company (2016-2021)
Table 64. China Leukocyte Surface Antigen CD47 Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Leukocyte Surface Antigen CD47 Revenue Market Share by Company (2016-2021)
Table 66. China Leukocyte Surface Antigen CD47 Sales by Type (2016-2021) & (K Pcs)
Table 67. China Leukocyte Surface Antigen CD47 Sales Market Share by Type (2016-2021)
Table 68. China Leukocyte Surface Antigen CD47 Sales by Type (2022-2027) & (K Pcs)
Table 69. China Leukocyte Surface Antigen CD47 Sales Market Share by Type (2022-2027)
Table 70. China Leukocyte Surface Antigen CD47 Sales by Application (2016-2021) & (K Pcs)
Table 71. China Leukocyte Surface Antigen CD47 Sales Market Share by Application (2016-2021)
Table 72. China Leukocyte Surface Antigen CD47 Sales by Application (2022-2027) & (K Pcs)
Table 73. China Leukocyte Surface Antigen CD47 Sales Market Share by Application (2022-2027)
Table 74. Japan Leukocyte Surface Antigen CD47 Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Leukocyte Surface Antigen CD47 Sales Market Share by Company (2016-2021)
Table 76. Japan Leukocyte Surface Antigen CD47 Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Leukocyte Surface Antigen CD47 Revenue Market Share by Company (2016-2021)
Table 78. Japan Leukocyte Surface Antigen CD47 Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Leukocyte Surface Antigen CD47 Sales Market Share by Type (2016-2021)
Table 80. Japan Leukocyte Surface Antigen CD47 Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Leukocyte Surface Antigen CD47 Sales Market Share by Type (2022-2027)
Table 82. Japan Leukocyte Surface Antigen CD47 Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Leukocyte Surface Antigen CD47 Sales Market Share by Application (2016-2021)
Table 84. Japan Leukocyte Surface Antigen CD47 Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Leukocyte Surface Antigen CD47 Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Leukocyte Surface Antigen CD47 Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Leukocyte Surface Antigen CD47 Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Leukocyte Surface Antigen CD47 Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Leukocyte Surface Antigen CD47 Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Leukocyte Surface Antigen CD47 Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Leukocyte Surface Antigen CD47 Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Leukocyte Surface Antigen CD47 Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Leukocyte Surface Antigen CD47 Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Leukocyte Surface Antigen CD47 Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Leukocyte Surface Antigen CD47 Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Leukocyte Surface Antigen CD47 Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Leukocyte Surface Antigen CD47 Sales Market Share by Application (2022-2027)
Table 98. India Leukocyte Surface Antigen CD47 Sales (K Pcs) by Company (2016-2021)
Table 99. India Leukocyte Surface Antigen CD47 Sales Market Share by Company (2016-2021)
Table 100. India Leukocyte Surface Antigen CD47 Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Leukocyte Surface Antigen CD47 Revenue Market Share by Company (2016-2021)
Table 102. India Leukocyte Surface Antigen CD47 Sales by Type (2016-2021) & (K Pcs)
Table 103. India Leukocyte Surface Antigen CD47 Sales Market Share by Type (2016-2021)
Table 104. India Leukocyte Surface Antigen CD47 Sales by Type (2022-2027) & (K Pcs)
Table 105. India Leukocyte Surface Antigen CD47 Sales Market Share by Type (2022-2027)
Table 106. India Leukocyte Surface Antigen CD47 Sales by Application (2016-2021) & (K Pcs)
Table 107. India Leukocyte Surface Antigen CD47 Sales Market Share by Application (2016-2021)
Table 108. India Leukocyte Surface Antigen CD47 Sales by Application (2022-2027) & (K Pcs)
Table 109. India Leukocyte Surface Antigen CD47 Sales Market Share by Application (2022-2027)
Table 110. Aurigene Discovery Technologies Ltd Corporation Information
Table 111. Aurigene Discovery Technologies Ltd Description and Business Overview
Table 112. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product
Table 114. Aurigene Discovery Technologies Ltd Recent Development
Table 115. Celgene Corp Corporation Information
Table 116. Celgene Corp Description and Business Overview
Table 117. Celgene Corp Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Celgene Corp Leukocyte Surface Antigen CD47 Product
Table 119. Celgene Corp Recent Development
Table 120. Forty Seven Inc Corporation Information
Table 121. Forty Seven Inc Description and Business Overview
Table 122. Forty Seven Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Forty Seven Inc Leukocyte Surface Antigen CD47 Product
Table 124. Forty Seven Inc Recent Development
Table 125. Surface Oncology Inc Corporation Information
Table 126. Surface Oncology Inc Description and Business Overview
Table 127. Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Surface Oncology Inc Leukocyte Surface Antigen CD47 Product
Table 129. Surface Oncology Inc Recent Development
Table 130. Trillium Therapeutics Inc Corporation Information
Table 131. Trillium Therapeutics Inc Description and Business Overview
Table 132. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product
Table 134. Trillium Therapeutics Inc Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Leukocyte Surface Antigen CD47 Distributors List
Table 138. Leukocyte Surface Antigen CD47 Customers List
Table 139. Leukocyte Surface Antigen CD47 Market Trends
Table 140. Leukocyte Surface Antigen CD47 Market Drivers
Table 141. Leukocyte Surface Antigen CD47 Market Challenges
Table 142. Leukocyte Surface Antigen CD47 Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Leukocyte Surface Antigen CD47 Product Picture
Figure 2. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type in 2021 & 2027
Figure 3. B-6H12 Product Picture
Figure 4. ALX-148 Product Picture
Figure 5. CC-90002 Product Picture
Figure 6. PSTx-23 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application in 2021 & 2027
Figure 9. Lymphoma Examples
Figure 10. Ovarian Cancer Examples
Figure 11. Ischemia Reperfusion Injury Examples
Figure 12. Kindney Transplant Rejection Examples
Figure 13. Others Examples
Figure 14. Global Leukocyte Surface Antigen CD47 Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Leukocyte Surface Antigen CD47 Sales Growth Rate (2016-2027) & (US$ Million)
Figure 16. Global Leukocyte Surface Antigen CD47 Sales (K Pcs) Growth Rate (2016-2027)
Figure 17. Global Leukocyte Surface Antigen CD47 Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 18. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region: 2016 VS 2021
Figure 19. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region: 2021 VS 2027
Figure 20. North America Leukocyte Surface Antigen CD47 Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. North America Leukocyte Surface Antigen CD47 Sales (K Pcs) Growth Rate (2016-2027)
Figure 22. Europe Leukocyte Surface Antigen CD47 Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Europe Leukocyte Surface Antigen CD47 Sales (Million USD) Growth Rate (2016-2027)
Figure 24. China Leukocyte Surface Antigen CD47 Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. China Leukocyte Surface Antigen CD47 Sales (Million USD) and Growth Rate (2016-2027)
Figure 26. Japan Leukocyte Surface Antigen CD47 Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Japan Leukocyte Surface Antigen CD47 Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Leukocyte Surface Antigen CD47 Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia Leukocyte Surface Antigen CD47 Sales (Million USD) Growth Rate (2016-2027)
Figure 30. India Leukocyte Surface Antigen CD47 Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. India Leukocyte Surface Antigen CD47 Sales (Million USD) Growth Rate (2016-2027)
Figure 32. Global 5 Largest Leukocyte Surface Antigen CD47 Players Market Share by Revenue in Leukocyte Surface Antigen CD47: 2016 & 2020
Figure 33. Leukocyte Surface Antigen CD47 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 34. Global Leukocyte Surface Antigen CD47 Revenue Share by Type (2016-2021)
Figure 35. Global Leukocyte Surface Antigen CD47 Revenue Growth Rate by Type in 2016 & 2020
Figure 36. Global Leukocyte Surface Antigen CD47 Revenue Share by Application (2016-2021)
Figure 37. Global Leukocyte Surface Antigen CD47 Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America Leukocyte Surface Antigen CD47 Sales Market Share by Type in 2020
Figure 39. North America Leukocyte Surface Antigen CD47 Sales Market Share by Application in 2020
Figure 40. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Type in 2020
Figure 41. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Application in 2020
Figure 42. China Leukocyte Surface Antigen CD47 Sales Market Share by Type in 2020
Figure 43. China Leukocyte Surface Antigen CD47 Sales Market Share by Application in 2020
Figure 44. Japan Leukocyte Surface Antigen CD47 Sales Market Share by Type in 2020
Figure 45. Japan Leukocyte Surface Antigen CD47 Sales Market Share by Application in 2020
Figure 46. Southeast Asia Leukocyte Surface Antigen CD47 Sales Market Share by Type in 2020
Figure 47. Southeast Asia Leukocyte Surface Antigen CD47 Sales Market Share by Application in 2020
Figure 48. India Leukocyte Surface Antigen CD47 Sales Market Share by Type in 2020
Figure 49. India Leukocyte Surface Antigen CD47 Sales Market Share by Application in 2020
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Leukocyte Surface Antigen CD47
Figure 52. Manufacturing Process Analysis of Leukocyte Surface Antigen CD47
Figure 53. Leukocyte Surface Antigen CD47 Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed